ScholarIQanswers from OpenAlex

A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy

PaperCitations, authors & open-access status

A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy have?

ScholarIQcitation count

A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy has 3 citations in the OpenAlex counts ScholarIQ stores.

When was A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy published?

ScholarIQyear

A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy has 2009 year in the ScholarIQ index.

What is the open-access status of A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy?

ScholarIQoa status

A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy has closed oa status in the ScholarIQ index.

What is the OpenAlex record for A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy?

ScholarIQopenalex

The OpenAlex for A Longer Monopoly for Biologics? Considering the Implications of Data Exclusivity as a Tool for Innovation Policy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial